FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,498,000 | -36.1% | 181,500 | 0.0% | 4.10% | -21.4% |
| Q1 2022 | $7,037,000 | -55.5% | 181,500 | -32.8% | 5.22% | -5.5% |
| Q4 2021 | $15,798,000 | -1.3% | 270,000 | 0.0% | 5.52% | +17.3% |
| Q3 2021 | $16,003,000 | -31.7% | 270,000 | 0.0% | 4.70% | -19.2% |
| Q2 2021 | $23,433,000 | +5.3% | 270,000 | 0.0% | 5.82% | +36.4% |
| Q1 2021 | $22,262,000 | -5.8% | 270,000 | +3.8% | 4.27% | +5.3% |
| Q4 2020 | $23,642,000 | – | 260,000 | – | 4.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |